These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12848633)

  • 21. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori eradication in functional dyspepsia: HEROES trial.
    Mazzoleni LE; Sander GB; Francesconi CF; Mazzoleni F; Uchoa DM; De Bona LR; Milbradt TC; Von Reisswitz PS; Berwanger O; Bressel M; Edelweiss MI; Marini SS; Molina CG; Folador L; Lunkes RP; Heck R; Birkhan OA; Spindler BM; Katz N; Colombo Bda S; Guerrieri PP; Renck LB; Grando E; Hocevar de Moura B; Dahmer FD; Rauber J; Prolla JC
    Arch Intern Med; 2011 Nov; 171(21):1929-36. PubMed ID: 22123802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.
    van Zanten SV; Flook N; Talley NJ; Vakil N; Lauritsen K; Bolling-Sternevald E; Persson T; Björck E; Svedberg LE;
    Aliment Pharmacol Ther; 2007 Sep; 26(5):665-72. PubMed ID: 17697200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial].
    Ruiz García A; Gordillo López FJ; Hermosa Hernán JC; Arranz Martínez E; Villares Rodríguez JE
    Med Clin (Barc); 2005 Mar; 124(11):401-5. PubMed ID: 15799844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment.
    Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
    Aliment Pharmacol Ther; 2003 Jul; 18(1):93-100. PubMed ID: 12848630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia.
    van Rensburg C; Berghöfer P; Enns R; Dattani ID; Maritz JF; Gonzalez Carro P; Fischer R; Schwan T
    Curr Med Res Opin; 2008 Jul; 24(7):2009-18. PubMed ID: 18534050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
    Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial.
    Corazziari ES; Gasbarrini A; D'Alba L; D'Ovidio V; Riggio O; Passaretti S; Annibale B; Cicala M; Repici A; Bassotti G; Ciacci C; Di Sabatino A; Neri M; Bragazzi MC; Ribichini E; Radocchia G; Iovino P; Marazzato M; Schippa S; Badiali D
    Am J Gastroenterol; 2023 Nov; 118(11):2014-2024. PubMed ID: 37307528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
    Färkkilä M; Sarna S; Valtonen V; Sipponen P;
    Scand J Gastroenterol; 2004 Apr; 39(4):327-35. PubMed ID: 15125464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia.
    Sandha GS; Hunt RH; Veldhuyzen van Zanten SJ
    Scand J Gastroenterol; 1999 Mar; 34(3):244-9. PubMed ID: 10232867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
    Lamouliatte H; Samoyeau R; De Mascarel A; Megraud F
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.
    Iwakiri R; Tominaga K; Furuta K; Inamori M; Furuta T; Masuyama H; Kanke K; Nagahara A; Haruma K; Kinoshita Y; Higuchi K; Takahashi S; Kusano M; Iwakiri K; Kato M; Hongo M; Hiraishi H; Watanabe S; Miwa H; Naito Y; Fujimoto K; Arakawa T
    Aliment Pharmacol Ther; 2013 Oct; 38(7):729-40. PubMed ID: 23957383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.
    Zeng J; Zuo XL; Li YQ; Wei W; Lv GP
    Eur J Clin Pharmacol; 2007 Jun; 63(6):529-36. PubMed ID: 17468863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?
    Hsu YC; Liou JM; Yang TH; Hsu WL; Lin HJ; Wu HT; Lin JT; Wang HP; Wu MS
    J Gastroenterol; 2011 Feb; 46(2):183-90. PubMed ID: 20957498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial.
    Laine L; Dhir V
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1143-8. PubMed ID: 12030957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia.
    Hsu PI; Lai KH; Tseng HH; Lo GH; Lo CC; Lin CK; Cheng JS; Chan HH; Ku MK; Peng NJ; Chien EJ; Chen W; Hsu PN
    Aliment Pharmacol Ther; 2001 Feb; 15(2):195-201. PubMed ID: 11148437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.